BOC Sciences Hosts Dr. Muzykantov of UPenn to Unveil Advances in Vascular Nano-Delivery

BOC Sciences hosts an exclusive virtual lecture featuring the distinguished Dr. Vladimir Muzykantov, a world-renowned expert in targeted drug delivery from the University of Pennsylvania.
 
The webinar, titled "Vascular Nano-Delivery Using Tropism and Targeting," will discuss current knowledge on vascular nanomedicine, focusing on how drug delivery systems (DDS) can be optimized to reach specific vascular targets. Prof. Muzykantov will talk about both cognizant targeting -- based on known binding sites -- and fortuitous tropism, in which delivery systems exhibit unexpected affinity or "homing" behaviors.
 
Event Details
Date: December 12th, 2025
Time: 10:00 AM EST
Format: Virtual Zoom Meeting
Online registration here
 
By inviting Dr. Muzykantov -- Founding Co-Director of the PSOM/SEAS Center for Targeted Therapeutics and Translational Nanomedicine (CT3N) at the University of Pennsylvania, an author of over 330 publications (h-index 87), and widely recognized as a foundational figure in vascular targeting therapies -- BOC Sciences demonstrates its strategic commitment to connecting its community with the visionary researchers who are shaping the future of medicine.
 
"We are beyond honored to host Dr. Muzykantov, whose seminal work literally laid the cornerstone for the field of vascular targeting research," said the event administrator of BOC Sciences.
 
This session is set to address one of the most pressing hurdles in pharmaceutical research today: achieving efficient and precise drug delivery. Addressing these challenges requires a robust and reliable platform of delivery technologies. As a leading drug discovery CDMO, BOC Sciences offers comprehensive solutions for designing, developing, and enhancing these critical delivery systems. Its strategies help scientists navigate biological barriers, improving drug bioavailability, safety, stability, and effectiveness.
 
BOC Sciences' expertise in advanced delivery carriers encompasses liposomes, nanoparticles, and microspheres. With years of experience, BOC Sciences ensures that researchers have access to the quality materials and technical support needed to expedite projects from the bench to the bedside. BOC Sciences shares a vision with researchers for the successful development of the next generation of targeted nanomedicines. This collaboration exemplifies its commitment to engaging with academia to address its latest challenges and advancements.
 
Registration for this defining event is now open. Any interested professionals are invited to join the session and connect with the insights that will impact the future of drug delivery research.
 
About BOC Sciences:
BOC Sciences is a supplier of premium chemicals, biochemicals, and drug discovery solutions, serving researchers and pharmaceutical companies across the globe. By facilitating knowledge-sharing with leading scientific minds, BOC Sciences remains committed to accelerating scientific discovery and therapeutic development.